MMND, 4th February, 2022 Program
7:45 -7:50 MMND Welcome (Anatoly Rosenfeld, Michael Lerch, Tomas Kron)
7:50-8:00 Opening by Prof David Currow , Deputy Vice Chancellor (Health and Sustainable Futures) UOW
Radiobiology and advancement of FLASH and spatially fractionated therapy session
Chair: Michael Lerch and Stephanie Corde –Tehei
8:00-8:30 Marie-Catherine Vozenin, Lausanne University Hospital
“FLASH radiotherapy: new radiobiology to support clinical translation”
8:40-9:10 Michael Krisch, ESRF, France
“Status and perspectives for MRT at the ESRF”
9:20-9:50 Yolanda Prezado, Institute Curie, France
“Protons and minibeam radiation therapy: a winning alliance”
Chairs: Joseph Bucci and Lois Holloway
10:00-10:30 Michael Zelefsky, MSKCC, NY
“The Value of Focal Dose Escalation Using MRI Linac for Localized Prostate Cancer”
10:40-11:10 Joseph Deasy, MSKCC, NY
“Clinical radiobiology through the lens of multimodality imaging”
11:10-11:40 Coffee Break/Industrial Exhibition
Advanced treatment planning in proton therapy session
Chairs: Tomas Kron and Linh Tran
11:40-12:10 Harald Paganetti, MGH, USA
“Online adaptive Proton Therapy”
12:10-12:40 Erik Traneous , RaySearch, Sweden
“Proton optimization beyond dose – promises and pitfalls”
12:40-13:00 Celebrity Groenendijk, Technical Uni Delft, Holland PT, The Netherlands
“3D LET characterization of the Holland PTC R&D proton beam line for radiobiological research”
13:00-14:00 Lunch and Industrial Exhibition
Advanced dosimetry and Monte Carlo simulations in ion therapy and space session
Chairs: Marco Petasecca and Susanna Guatelli
14:00-14:20 Reinhard Schulte, Loma Linda, USA
“Advanced Beam Monitor for FLASH and Mini-Beam Radiotherapy”
14:20-14:40 Taku Inaniwa, QST, Japan
“Development of Multi Ion Therapy at QST”
14:40-15:00 Dousatsu Sakata, QST, Japan
“Prediction of DNA rejoining kinetics and cell survival of HSGC-C5 carcinoma cells using Geant4-DNA”
15:00-15:15 Yoshihide Sato, QST, Japan
“Assessment of fragmentation model in heavy ion therapy”
15:15-15:30 James C E Lee, National Cancer Centre, Singapore
”Research and innovation at NCCS”
15:30-15:50 Yigal Horowitz , Ben Gurion University, Israel
“Extended dose response linearity beyond 1 Gy in LiF:Mg,Ti (TLD-100) using photon excitation post-irradiation”
15:50-16:05 Yulia Akisheva ISAE-SUPAERO, France
“Regolith as a radiation shield for habitants on the Moon”
16:05-16:30 Coffee Break/Industrial Exhibition
Innovations in radiobiology and in ion accelerators for therapy session
Chairs: Anatoly Rosenfeld, Eva Bezak and Moeava Tehei
16:30-17:00 Francis Cucinotta, University NevadaLas Vegas, USA
“Innovations in Radiobiology with Relevance to Space Missions and Normal Tissue Damage in Oncology”
17:00-17:30 Marco Durante, GSI , Germany
“Pre-clinical radiobiology at GSI”
17:30-18:00 Dale Prokopovich, MedAustron, Austria
“The MedAustron Particle Therapy Facility – Recent and Future Developments”
19:00 Pre-dinner drinks and dinner
ITRO, 5th February, 2022 Program
7:45 -8:00 ITRO Welcome (Josh Yamada and Anatoly Rosenfeld)
Modifying the Biologic Response with Modern Radiotherapy Session
Chairs: Josh Yamada and Michael Jackson
8:00-8:30 Josh Yamada, MSKCC, New York, USA
“The Role of Dynamic Contrast Enhanced MRI in the Management of Spine Metastases with SBRT”
8:30-8:40 Discussion
8:40-9:10 Nancy Lee, MSKCC, New York, USA
“Precision Radiation for HPV-related Oropharyngeal Carcinoma: The 30 ROC trial”
9:10-9:20 Discussion
9:20-9:50 Joseph Deasy, MSKCC, New York, USA
“Predictive and Adaptive Radiotherapy (PreART): a new paradigm for radiotherapy personalization”
9:50-10:00 Discussion
10:00-10:30 Igor Barani, Barrow Neurological Institute, AZ, USA
“Tissue-based Trialling to Investigate Glioma Radiosensitizer Strategies.”
10:30-10:40 Discussion
10:40-11:10 Coffee Break/Industrial Exhibition
Particle Therapy: FLASH proton therapy and other Innovations in proton therapy session
Chairs: Carl Rossi and Verity Ahern
11:10-11:40 Costas Koumenis, University of Pennsylvania, USA
“Preclinical studies on FLASH proton therapy in mice and canine patients: the Penn experience”
11:40-12:10 John Breneman, Cincinnati Children’s/UC Health Proton Therapy Center, USA
“Implementation and conduct of the first in-human trial of FLASH radiotherapy
12:10-12:40 Carl Rossi, California Proton Therapy Center, San Diego, USA
“Looking Beyond FLASH-Other clinical innovations in proton therapy
12:40-13:00 Discussion
13:00-14:00 Lunch and Industrial Exhibition
State-of-the-Art in future particle therapy facilities and X-ray SBRT session
Chairs: Michael Penniment and Annette Haworth
14:00-14:25 Chris Beltran, Mayo Clinic, Florida, USA
“Carbon: high LET Therapy at Mayo Clinic Jacksonville Florida”
14:25-14:45 Michael Penniment Bragg Inst. for PT, Adelaide
“Introducing Proton Therapy to the Australian Radiation Oncology Framework”
14:45-15:05 Scott Penfold Bragg Inst. for PT, Adelaide
“Australian Bragg Centre Construction Update and Potential of Upright Patient Positioning”
15:05-15:30 Shankar Siva, Peter McCullum Cancer Centre, Melbourne
“State of the art in SABR for oligometastatic disease”
15:30-16:00 Round table discussion, young registrars and student presentations
Chairs: Peter Metcalfe and Paul Keall
15:30-15:35 Eric Fong, Prince of Wales Hospital, Sydney
“Photon SBRT for ocular melanoma”
15:35-15:40 Gargi Kothari, Peter MacCallum Cancer Centre, Melbourne
“The role of radiomics in lung cancer”.
15:40-15:45 Nick Bucknell, Peter MacCallum Cancer Centre, Melbourne
“Personalised Radiation Therapy – the role of functional imaging to reduce dose to organs at risk”
15:45-15:50 Irina Kempf , University of Zurich, Switzerland
“FIRE detector – Research and Development of a portable nanodosimeter”
16:00-16:30 Coffee Break/Industrial Exhibition
Innovations in carbon ion therapy and Boron Neutron Capture therapy session
Chairs: Viet Do and Anna Ralston
16:30-17:00 Piero Fossati, MedAustron, Austria
“Modern Carbon Ion planning in the clinics at MedAustron: is a deterministic RBE the best way to go?”
17:10-17:40 Wolfgang Sauerwein, German Society for BNCT, Germany
“Dawn for BNCT? Recent developments and short-term prospects”
17:50-18:00 Closing
19:00 Dinner / Pre-dinner drinks